Biotech · Private company · Cary, NC, US
Allucent Government Services (Us) LLC
Track this companyFree. Adds Allucent Government Services (Us) LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards10
- Early Phase Clinical Trial Units (EPCTU)Fiscal year 2026 · $148.1KNIH RePORTER 75N93022D00015-P00004-759302200001-1 · fetched Nov 12, 2026
- DMPK Subject Matter Expert support services for NINDS BPN and HEAL drug development programs.Fiscal year 2026 · $3.3KNIH RePORTER 75N98026P00877-0-0-1 · fetched Nov 12, 2026
- DMPK Subject Matter Expert support services for NINDS BPN and HEAL drug development programs.Fiscal year 2026 · $11.7KNIH RePORTER 75N98026P00877-0-0-2 · fetched Nov 12, 2026
- Early Phase Clinical Trial Units (EPCTU)Fiscal year 2025 · $143.8KNIH RePORTER 75N93022D00015-P00003-759302200001-1 · fetched Nov 12, 2026
- SUBJECT MATTER EXPERT CONSULTANT FOR DRUG METABOLISM PHARMACOKINETICS [DMPK] - HEALFiscal year 2025 · $58.4KNIH RePORTER 75N95022P00352-P00009-0-1 · fetched Nov 12, 2026
- This service is for Micro Contract for DMPK Expert services for BPN, HEAL and Biologics. Incumbent is Devin Welty, PH.D.; POP: 07/01/2025 to 06/30/2026.Fiscal year 2025 · $5.8KNIH RePORTER 75N95A25P00069-0-0-1 · fetched Nov 12, 2026
- HEAL - This service is for Micro Contract for DMPK Expert services for BPN, HEAL and Biologics. Incumbent is Devin Welty, PH.D.; POP: 07/01/2025 to 06/30/2026.Fiscal year 2025 · $4.2KNIH RePORTER 75N95A25P00069-0-0-2 · fetched Nov 12, 2026
- This service is a MicroContract for DMPK Expert services for BPN, HEAL and Biologics. Incumbent is Gene Williams, Ph.D. POP: 07/01/2025 to 06/30/2026.Fiscal year 2025 · $1.5KNIH RePORTER 75N95A25P00073-0-0-1 · fetched Nov 12, 2026
- This service is a MicroContract for DMPK Expert services for BPN, HEAL and Biologics. Incumbent is Gene Williams, Ph.D. POP: 07/01/2025 to 06/30/2026. HEALFiscal year 2025 · $8.5KNIH RePORTER 75N95A25P00073-0-0-2 · fetched Nov 12, 2026
- Task C1: Phase I Clinical Trial to Evaluate Influenza TherapeuticsFiscal year 2024 · $3.2MNIH RePORTER 75N93022D00015-0-759302400001-1 · fetched Nov 12, 2026